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Abstract 
Background: This study evaluated the correlation of single nucleotide polymorphisms interleukin (IL)-10-592 and 
-1082 with hepatitis B virus (HBV) susceptibility and recovery.
Methods: Total 190 chronic hepatitis B (CHB) patients, 81 individuals with self-limited HBV infections and 81 normal 
controls from the first Hospital of Jilin University were recruited. The IL-10 polymorphisms were detected by polymer-
ase chain reaction with restriction fragment length polymorphism (PCR–RFLP). The χ2 test (p < 0.05) and Fisher’s exact 
test were separately performed to analyze and compare the genotype frequencies of IL-10-592 and -1082 among 
different groups. Furthermore, logistic regression analysis (p < 0.05) was conducted to determine the correlation of 
genotypes with HBV infection and recovery. Genotype A/A, A/C and C/C of IL-10-592 had been detected in the three 
groups.
Results: The frequencies of -592A separately were 55.56, 64.67 and 55.33 % in the three groups. Genotypes of IL-10-
592 only had significant difference among the patients and normal controls (p = 0.021). Genotypes A/A, A/G and G/G 
of IL-10-1082 were detected in CHB patients and individuals with self-limited HBV infection; however, genotype G/G 
had not been detected in normal controls. The frequencies of -1082G separately were 3.68, 6.17 and 11.11 % in the 
three groups. Genotypes of IL-10-1082 only had no significant difference among the patients and individuals with 
self-limited HBV infections (p = 0.130). We found that their risks of HBV infection existed significant difference.
Conclusion: The IL-10-592 and -1082 polymorphisms might be associated with HBV infection, but not with the 
recovery after HBV infection.
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Background
Hepatitis B virus (HBV) infection is the main cause for 
acute and chronic hepatitis. Besides, HBV infection is 
closely related to the incidence of liver cirrhosis and 
hepatocellular carcinoma. Particularly, in China, its prev-
alence is high. Among the adults with the initial infec-
tion of HBV, approximately 85 % can recover, and about 
10–15 % may turn into chronic hepatitis. And among the 
patients with chronic hepatitis, approximately 20–30  % 
would develop into liver cirrhosis. After being infected 
with HBV, human body can present several different clin-
ical outcomes, which are affected by genetic, immunolog-
ical, virological and experimental factors [1].
Numerous researches have focused on the relation-
ship between cytokine genetic polymorphisms and the 
susceptibility to HBV [2–15]. Interleukin-10 (IL-10) is 
a crucial immunoregulatory cytokine secreted by cells 
including T regulatory lymphocytes, and activated T 
helper (Th) 2 cells and macrophages [9]. By directly 
affecting the production of tumor necrosis factor, 
IL-10 can take part in the regulation of inflammatory 
responses [16]. The promoter region contains several 
components of transcription factors, which is closely 
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single nucleotide polymorphisms (SNPs) of IL-10 pro-
moter affect the expression level of IL-10. Many SNPs 
in the proximal promoter of IL-10 have been studied to 
investigate their association with HBV infection, such as 
polymorphisms on -592 site [19–21], -819 site [10, 11, 
20], -872 site [22], and -1082 site [8, 9, 21]. However, pol-
ymorphisms on -592 site and -1082 site have not been 
determined among chronic hepatitis B (CHB) patients, 
self-limited HBV infection and normal controls in Han 
population yet.
By comparing the distribution frequency of different 
genotypes of IL-10-592 site and IL-10-1082 site in CHB 
patients, individuals with self-limited HBV infections 
and normal controls, this study attempted to determine 
whether gene polymorphisms in IL-10-592 and IL-10-




A total of 190 CHB patients (144 men and 46 women; 
average age, 41.55  ±  9.55  years) were from infectious 
diseases department of the first Hospital of Jilin Uni-
versity, whose diagnosis was based on “The guideline of 
prevention and treatment for chronic hepatitis B” pub-
lished by Chinese Society of Hepatology and Chinese 
Society of Infectious Diseases, Chinese Medical Associa-
tion in 2005. A total of 81 individuals with self-limited 
HBV infection cases (60 men and 21 women; average 
age, 42.51  ±  11.30  years) were from the target groups 
of epidemiological investigation by infectious diseases 
department, which were defined as patients with no his-
tory of hepatitis B, with normal liver function, whose 
HBV serum markers showed hepatitis B surface anti-
body (HBsAb) and hepatitis B core antibody (HBcAb) 
positive while hepatitis B surface antigen (HbsAg) and 
hepatitis Be antigen (HBeAg) negative. And a total of 
81 normal control cases (58 men and 23 women; aver-
age age, 41.59 ±  11.79  years) were also from the target 
groups of epidemiological investigation, in which people 
were healthy according to medical examination. Further-
more, all the participants were Han people in northern 
China. This project was approved by the ethical commit-
tee of the first Hospital of Jilin University (the reference 
number: 2014-224 and 2014-225) and informed consents 
were signed by all participants before study initiation.
Specimen collection
Fasting blood taken in the early morning was added into 
the test tube with EDTA-K2 anticoagulant and reserved 
after fully mixed. Genomic DNA was extracted from 
peripheral blood leucocytes using DNA extraction kit 
(Promega, Wisconsin, USA), and then stored at −20 °C.
Genotyping
Two SNPs of IL-10 (IL-10-592 and IL-10-1082) were 
detected and genotyped using polymerase chain reac-
tion with restriction fragment length polymorphism 
(PCR–RFLP). Their corresponding primers (Sangon, 
Shanghai, China) were designed using the standard 
sequences rs1800872 and rs1800896 from SNPs database 
website as templates. The primers used for rs1800872 
included the forward primer: 5′-GGTGAGCACTACC 
TGACTAGC-3′ and the reverse primer: 5′-TAGGTCAC 
AGTGACGTGG-3′. The primers used for rs1800896 
included the forward primer: 5′-CTCGCCGCAACCC 
AACTGGC-3′ and the reverse primer: 5′-GTAAGGGACC 
TCCTATCCAG-3′. PCR was conducted in a volume of 
50  μL with 25  μL 2×  Taq Plus PCR MasterMix (TIAN-
GEN, Beijing, China), and concentration of each primer 
was 20  pmol/μL. PCR was carried out under the condi-
tions: 94 °C for 5 min, 30 cycles for 94 °C 45 s, 61 °C 45 s, 
72 °C 1 min, and 72 °C for 10 min. RFLP digestion system 
was carried out in a volume of 20 μL with 0.1–0.5 μg the 
PCR product, 0.5  μL (5  u/μL) MnlI restriction enzyme, 
2 μL 10× NEB buffer, 0.2 μL 100× BSA, 17.3 μL sterilized 
double-distilled water. The digested condition was 37  °C 
for 4  h. We used 2.0  μg digestion products to perform 
agarose gel electrophoresis and then observed the results 
under the gel imaging system (TANON, Shenyang, China).
Statistical analysis
Statistical tests including the χ2 test and Fisher’s exact 
test were conducted using the SPSS 11.5 software.  The 
Hardy–Weinberg (H–W) equilibrium and frequencies of 
the genotypes among different groups were compared. 
The χ2 tests were performed to analyze the genotype fre-
quency of IL-10-1082 G/A among different groups. The 
95  % confidence interval (95  % CI) and the odds ratio 
(OR) were calculated. Logistic regression analysis was 
also used to determine the correlation of a specific geno-
type with HBV infection and recovery. p < 0.05 was con-
sidered as statistically significant.
Results
Three genotypes of IL‑10‑592 and IL‑10‑1082 were 
detected in Han population
The 410-bp sequences in IL-10-592 promoter were 
amplified by normal PCR and analyzed by RFLP. Three 
RFLP patterns appeared after digestion with the restric-
tion enzyme RsaI (Fig. 1). The band in lane 1 was 410 bp 
and its genotype was C/C. The genotype of the two 
bands of 234 and 176 bp observed in lane 2 was A/A. The 
bands in lane 3 separately were 410, 234 and 176 bp, and 
their genotype was A/C. Overall, we found three IL-10-
592 genotypes A/A, A/C and C/C in Han population of 
northern China.
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The 159-bp sequences in IL-10-1082 promoter were 
amplified by normal PCR and analyzed by RFLP. Three 
RFLP patterns appeared after digestion with the restric-
tion enzyme MnlI (Fig. 2). The band in lane 1 was 159 bp 
and its genotype was A/A. The genotype of the three 
bands of 159, 103 and 56 bp observed in lane 2 was A/G. 
And, the bands in lane 3 were 103 and 56 bp, and their 
genotype was G/G. In general, this study found three 
genotypes A/A, A/G and G/G in Han population of 
northern China.
Distribution frequencies of IL‑10‑592 and IL‑10‑1082 
genotypes
We analyzed the distribution frequencies of different 
genotypes of IL-10-592 and IL-10-1082 among CHB 
patients, individuals with self-limited HBV infections 
and normal controls (Table 1). The genotype frequencies 
of IL-10-592 and IL-10-1082 among these three groups 
all met the H–W equilibrium. The genotype frequen-
cies of A/A, A/C and C/C on -592 site were 25.56, 60.00 
and 14.44 % in CHB patients, 40.00, 49.33 and 10.67 % in 
individuals with self-limited HBV infections, and 34.67, 
41.33 and 24.00 % in normal controls, respectively. Thus, 
the frequencies of -592A separately were 55.56, 64.67 and 
55.33  % in CHB patients, individuals with self-limited 
HBV infections and normal controls. The genotype fre-
quencies of G/G, A/G and A/A on -1082 site were 0.53, 
6.32 and 93.16 % in CHB patients; 3.70, 4.94 and 91.36 % 
in individuals with self-limited HBV infections; and 
0.00, 22.22 and 77.78 % in normal controls, respectively. 
Therefore, the frequencies of -1082G were 3.68, 6.17 and 
11.11  % in CHB patients, individuals with self-limited 
HBV infections and normal controls, respectively. Then, 
χ2 tests were performed.
Genotype A/A, A/C and C/C of IL-10-592 had been 
detected in the three groups. According to continuity 
correction χ2 tests, genotype C/C frequency increased 
significantly (χ2 =  7.742, p =  0.021) in normal controls 
compared with CHB patients. Furthermore, genotype 
frequencies of individuals with self-limited HBV infec-
tions versus normal controls (χ2  =  4.661, p  =  0.097), 
and CHB patients versus individuals with self-limited 
HBV infections (χ2 = 5.332, p = 0.070) had no significant 
difference.
Genotype A/A of IL-10-1082 was the highest frequency 
in all of the participants, while genotypes A/G and G/G 
were relatively rare. Particularly, in the normal controls, 
genotype G/G had not been detected. By continuity cor-
rection χ2, we compared genotype frequencies of CHB 
patients with normal controls. In patients, genotype A/A 
frequency increased significantly, while A/G frequency 
reduced (χ2 = 13.883, p = 0.001). Besides, by continuity 
correction χ2, we compared that of individuals with self-
limited HBV infections with normal controls. In indi-
viduals with self-limited HBV infections, genotype A/A 
Fig. 1 Electrophoresis result of IL-10-592 polymorphisms. M: DL2000 
DNA marker, 100, 250, 500, 750, 1000, 2000 bp from bottom to top of 
the gel; lane 1 genotype C/C; lane 2 genotype A/A; lane 3 genotype 
A/C
Fig. 2 Electrophoresis result of IL-10-1082 polymorphisms. M: 
DL2000 DNA marker, 100, 250, 500, 750, 1000, 2000 bp from bottom 
to top of the gel; lane 1 genotype A/A; lane 2 genotype A/G; lane 3 
genotype G/G
Table 1 Genotype frequencies of IL-10-592 and IL-10-1082 
in the three groups









IL-10-592 A/A 46 (25.56) 30 (40.00) 26 (34.67)
A/C 108 (60.00) 37 (49.33) 31 (41.33)
C/C 26 (14.44) 8 (10.67) 18 (24.00)
IL-10-1082 G/G 1 (0.53) 3 (3.70) 0 (0.00)
A/G 12 (6.32) 4 (4.94) 18 (22.22)
A/A 177 (93.16) 74 (91.36) 63 (77.78)
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frequency increased significantly, while A/G frequency 
reduced (χ2  =  14.679, p  =  0.001). Furthermore, by the 
Fisher exact probabilistic method, we compared geno-
type frequencies of CHB patients with individuals with 
self-limited HBV infections. Different genotype frequen-
cies between the two groups had no significant difference 
(p = 0.130).
Association of IL‑10‑592 and IL‑10‑1082 polymorphisms 
with HBV infection
Using logistic regression, the association of IL-10-592 
genotypes with HBV infection among CHB patients 
and normal controls were compared (Table  2). The risk 
of HBV infection of genotype A/C carriers was 2.412 
times of the genotype C/C carriers (OR  =  2.412, 95  % 
CI 1.172–4.963). Thus, the risk of HBV infection had sig-
nificant difference between genotype A/C carriers with 
genotype C/C carriers (p < 0.05).
We compared the association of IL-10-1082 genotypes 
with HBV infection among CHB patients and normal 
controls using logistic regression (Table  2). The risk of 
HBV infection had significant difference between geno-
type A/G carriers with genotype A/A carriers (p < 0.05). 
In detail, the risk of HBV infection of genotype A/G car-
riers was only 0.237 times of the genotype A/A carriers 
(OR = 0.237, 95 % CI 0.108–0.520), while that of G allele 
carriers (A/G + G/G) was 0.257 times of the homozygous 
AA-type carriers (OR = 0.257, 95 % CI 0.119–0.555).
Afterward, we compared the association of IL-10-1082 
genotypes with HBV infection among self-limited HBV 
infections and normal controls using logistic regression 
(Table  3). In detail, the risk of HBV infection of geno-
type A/G carriers was only 0.189 times of the genotype 
A/A carriers (OR =  0.189, 95  % CI  0.061–0.588), while 
that of G allele carriers (A/G  +  G/G) was 0.331 times 
of the homozygous AA-type carriers (OR = 0.331, 95 % 
CI  0.130–0.844). Therefore, the risk of HBV infection 
had significant difference between genotype A/G carriers 
with genotype A/A carriers (p < 0.05).
Discussion
In this study, we identified the polymorphisms of -592 
and -1082 in the IL-10 promoter region and the corre-
lation of these polymorphisms with HBV susceptibility 
and recovery in Han population. Genotype A/A, A/C and 
C/C of IL-10-592 had been detected in the three groups. 
Similarly, genotypes A/A, A/G and G/G of IL-10-1082 
were found in patients and individuals with self-limited 
HBV infections, while genotype G/G was not observed in 
normal controls.
After HBV infection, the immune response can be 
induced to eliminate the virus. As a crucial Th-2 cell 
cytokine, IL-10, whose expression can be effected by 
the polymorphisms in the regulatory regions, plays an 
important role in immune responses [23]. Crawley et al. 
[24] found that IL-10-1082, -819, -592 could link to dif-
ferent haplotypes. Haplotype carrying the homozygous 
ATA was with low level of IL-10 while haplotype carry-
ing the homozygous GCC was with high level of IL-10. 
Meanwhile, the ACC (-1082, -819 and -592) haplotype 
could improve individuals’ anti-hepatitis B surface anti-
gen (anti-HBs) antibody production almost twice of 
individuals without this haplotype, while -1082A allele 
could suppress individuals’ anti-hepatitis A virus (anti-
HAV) antibody production in comparison to individuals 
homozygous for the -1082G allele homozy [11].
This study found that -592G mutated into -592A 
could enhance the susceptibility to HBV, while -1082A 
mutated into -1082G could reduce the susceptibility 
to HBV. Thus, -1082G allele was the protective factor 
against HBV infection, and the SNPs of IL-10 at -592 
and -1082 sites were associated with HBV infection. 
This was in accordance with the results of Cheong et al. 
[10], Shin et al. [25] and Miyazoe et al. [2]. In contrary, 
Gao et  al. [9] found that both IL-10-1082 A/G alleles 
and IL-10-1082 AA/AG genotypes did not have sig-
nificant difference between patients with HBV-infected 
individuals and controls. By conducting meta-analysis, 
Table 2 The risk analysis of IL-10-592 and IL-10-1082 poly-
morphisms associated with  HBV infection (the patients 
versus the normal controls)
SNP single nucleotide polymorphism, OR odds ratio, 95 % CI, 95 % confidence 
interval, A allele A/A + A/C, G allele A/G + G/G
* p < 0.05
SNPs Genotype OR 95 % CI p
IL-10-592 C/C 1 – –
A/A 1.225 0.567–0.502 2.645
A/C 2.412 1.172–4.963 0.017*
A allele 1.870 0.954–3.668 0.068
IL-10-1082 A/A 1 – –
A/G 0.237 0.108–0.520 0.00*
G allele 0.257 0.119–0.555 0.001*
Table 3 The risk analysis of  IL-10-1082 polymorphisms 
associated with  HBV infection (individuals with  self-lim-
ited infections versus the normal controls)
SNP single nucleotide polymorphism, OR odds ratio, 95 % CI 95 % confidence 
interval, G allele A/G + G/G
* p < 0.05
SNP OR 95 % CI p
A/A 1 – –
A/G 0.189 0.061–0.588 0.004*
G allele 0.331 0.130–0.844 0.021*
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Lu et al. [26] demonstrated that IL-10-1082 A/G alleles 
have no relation to HBV infection in the Asian popu-
lation. Wu et  al. [27] found that the polymorphisms 
of IL-10-1082 G/G genotype have correlation with 
lower HBV viral load and earlier HBeAg seroconver-
sion. Zhang et  al. [28] deemed that the SNPs of IL-10 
promoter have no correlation with the susceptibility to 
HBV and DNA replication of HBV after infection, but 
the SNPs of IL-10 at -819 and -592 sites had association 
with liver inflammation.
Various regulatory and proinflammatory cytokines, 
such as IL-10, interleukin-12 (IL-12) and interferon-γ 
(IFN-γ), can change the course of chronic HBV infec-
tion, but their effects on HBV recovery are not entirely 
clear [8, 29–31]. We found that genotypes of IL-10-592 
only had significant difference among the patients and 
normal controls (p = 0.021). Genotypes of IL-10-1082 
had significant difference in the patients versus normal 
controls (p  =  0.001) and individuals with self-limited 
HBV infections versus normal controls (p = 0.001), but 
not among the patients and individuals with self-lim-
ited HBV infections (p = 0.130). So we could conclude 
that compared with the normal controls, the patients 
and the individuals with self-limited HBV infections 
were more susceptible to HBV. Thus, the SNPs of IL-10 
at -592 and -1082 sites had no correlation with HBV 
recovery. And this was in accordance with the results of 
Sofian et al. [20]. However, the G allele at IL-12β SNP 
rs3212217 (IL-12β-10993) and A allele at IL-10 SNP 
rs1800872 (IL-10-592) have been reported to predict 
greater peak alanine aminotransferase (ALT) levels in 
the immune-clearance phase, and also predict spon-
taneous HBsAg seroconversion/HBV recovery [32]. 
These conflicting findings might be resulted by influ-
ence of other genes, numbers of participants, charac-
teristics of patients, and many other geographical or 
epidemiological factors. In the present study, the num-
ber and characteristics of participants were limited, 
and confounding factors were not determined. Consid-
ering these limitations, further studies should be done 
to confirm our findings.
Conclusion
In conclusion, the polymorphisms of IL-10-592 and 
IL-10-1082 might be associated with the susceptibility to 
HBV in Chinese Han population. However, the polymor-
phisms at -592 and -1082 sites might have no correlation 
with the turnover after HBV infection.
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